Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A151-A151, February 1, 2025. Introduction:Stroke is a leading cause of maternal morbidity and mortality, and the incidence of maternal stroke is triple that of age-matched, non-pregnant counterparts. Characteristics of the study population are shown in the Table.

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP62-ATMP62, February 1, 2024. Introduction:Seizures are a common initial manifestation of cerebral venous thrombosis (CVT). Risk factors included intracranial hemorrhage (OR 2.0 The primary outcome was delayed seizure(s), occurring after 7 days from CVT diagnosis.

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionUp to 18% of spontaneous intracerebral hemorrhages are cryptogenic despite a thorough workup, usually noted in a lobar location. CT revealed a left parasagittal hemorrhage. CT revealed a right parasagittal hemorrhage.

Hemorrhage 40

Hemorrhage AFIB Cerebrovascular Disease Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Both anticoagulants can be used intraoperatively and postoperatively for DVT prophylaxis in patients undergoing subarachnoid hemorrhage (SAH) treatment. SAH severity was determined using the National Institute of Health Stroke Scale as a template.

Hemorrhage 40

Hemorrhage Aneurysm Outcomes Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP149-AWP149, February 1, 2024. Background:Direct oral anticoagulants (DOACs) are suitable for some patients with cerebral venous thrombosis (CVT). The primary outcome at day 90 (D90) was a composite of CVT recurrence/extension and symptomatic intracranial hemorrhage (sICH). 1-4d, 23.8%

Thrombosis 40

Thrombosis Outcomes Hemorrhage Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2025. Background and Purpose:External counterpulsation (ECP) is a novel noninvasive method used to improve the perfusion of vital organs, which may benefit ischemic stroke patients. of 65 patients in ECP group compared to 9.1%

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP259-AWP259, February 1, 2024. Cases had a maternal stroke (ischemic, hemorrhagic, subarachnoid hemorrhage, or cerebral venous thrombosis) during pregnancy or PP, identified from a stroke registry. Population characteristics are shown in the Table.

Hypertension 40

Hypertension Stroke Strokes Blood Pressure 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP67-ATP67, February 1, 2025. Introduction:Ongoing staff stroke education is crucial to ensure that stroke knowledge remains current and at the forefront of everyone's minds and is also required for stroke certification.

Education 40

Education Stroke Strokes Certification 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP154-AWP154, February 1, 2024. Prolonged ICU stay were more likely to have higher baseline median NIHSS score (19 vs. 14%, p < 0.0001), posterior circulation stroke (12.6% vs. 6.1%, p = 0.0002), deep vein thrombosis (7.3 vs. 6.1%, p = 0.0002), deep vein thrombosis (7.3

ICU 40

ICU Thrombolysis Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

OCTOBER 2, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. BackgroundProcedural intravenous cangrelor has been proposed as an effective platelet inhibition strategy for stenting in acute ischemic stroke. P=0.837), symptomatic intracranial hemorrhage–parenchymal hematoma type 2 (OR, 0.54 [95% CI, 0.05–4.98];P=0.589),

Hemorrhage 40

Hemorrhage Thrombosis Stent Stents 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A16-A16, February 1, 2024. Neutrophils are major contributors to cerebral thrombosis and oxidative stress following subarachnoid hemorrhage (SAH); however, the mechanism by which neutrophil integrin α9 contributes to SAH pathogenesis is unclear.

Hemorrhage 40

Hemorrhage Thrombosis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP85-ATMP85, February 1, 2025. MRIs were scored as mild if there was isolated DMVT with no or only punctate parenchymal injury; moderate if there was DMVT with focal, unilateral ischemic or hemorrhagic injury, and severe if there was bilateral, confluent ischemic or hemorrhagic injury.

Thrombosis 40

Thrombosis Hemorrhage Congenital Outcomes 40

Stroke Journal

MARCH 11, 2024

Stroke, Ahead of Print. Historically, the research literature overwhelmingly emphasized the future hemorrhagic risk associated with CMBs, potentially leading to unnecessary withholding of treatments proven effective at preventing thrombosis, such as anticoagulants in patients with atrial fibrillation who happened to have some microbleeds.

Hemorrhage 40

Hemorrhage Atrial Fibrillation Thrombosis Article 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionSubarachnoid Hemorrhage (SAH) resulting from the spontaneous rupture of an aneurysm is a rare and highly debilitating condition.

Hemorrhage 40

Hemorrhage Aneurysm Cardiac Arrest Myocardial Infarction 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. were included from each dataset.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Stroke Journal

NOVEMBER 27, 2024

Stroke, Volume 56, Issue 1 , Page 5-13, January 1, 2025. BACKGROUND:Lack of a dedicated thrombectomy device for cerebral venous thrombosis hinders the recanalization ability of endovascular treatment (EVT). Novel NiTi-braided stent retriever (Venous-TD) is a dedicated venous sinus thrombectomy device.

Thrombosis 40

Thrombosis Stent Stents Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Seven patients had strokes of any kind, three of which were unrelated to the treatment territory, and two of the remaining 4 were non‐compliant with antiplatelet therapy. One patient had a new intraparenchymal hemorrhage, but no appreciable deficit.

Embolism 40

Embolism Aneurysm Hemorrhage Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The suggested DCV pathophysiologic mechanisms involve vascular inflammation and delayed cerebral thrombosis (DCT). Intra‐arterial and intrathecal vasodilators have been reportedly used with variable outcomes.

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Research 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. She was noted to have incidental left internal jugular (IJ) vein thrombosis for which anticoagulation was held in the setting of recent neurosurgical procedure and SAH. Cerebral vasospasm following EEA has rarely been described.

Blood Pressure 40

Blood Pressure Stenosis Hemorrhage Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Ahead of Print. Primary end point was a composite of ischemic stroke, myocardial infarction, or other arterial thrombotic events. Primary end point was a composite of ischemic stroke, myocardial infarction, or other arterial thrombotic events. 0.81) for the 0- to 1-year score, 0.672 (95% CI, 0.58–0.73)

Thrombosis 40

Thrombosis Hemorrhage Coronary Artery Disease Myocardial Infarction 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP108-ATMP108, February 1, 2024. Background:Prognostication following cerebral venous thrombosis (CVT) remains challenging. Mortality is an uncommon yet catastrophic outcome after CVT.

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe use of detachable coils for endovascular embolization of cerebral aneurysms has become a safe and effective alternative to direct surgical clipping in patients with ruptured aneurysmal subarachnoid hemorrhage.

Aneurysm 40

Aneurysm Stent Stents Hemorrhage 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP364-AWP364, February 1, 2025. proposed an innovative thromboembolic stroke model in mice where murine thrombin is injected into the M2 segment of the middle cerebral artery (MCA) to induce arterial thrombosis. Introduction:In 2007, Orset et al.

Pharmacology 40

Pharmacology Stroke Strokes Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP267-ATP267, February 1, 2024. Introduction:Exposure to high altitude environment is a risk factor of cerebral venous thrombosis (CVT) probably due to the hypercoagulability. Hemorrhage (44.2% The median age was 31 and 35 years old, and women accounted for 65.1% respectively.

Thrombosis 40

Thrombosis Risk Factors Hospital Hemorrhage 40

Stroke: Vascular and Interventional Neurology

AUGUST 26, 2024

Stroke: Vascular and Interventional Neurology, Ahead of Print. The most common cerebrovascular disease complicating bacterial meningitis are cerebral infarctions (9%25%), intracerebral hemorrhage (1%7%), cerebral venous thrombosis (1%10%), and subarachnoid hemorrhage (1%5%).Streptococcus

Cerebrovascular Disease 40

Cerebrovascular Disease Hemorrhage Thrombosis Outcomes 40

Stroke Journal

DECEMBER 9, 2024

Stroke, Volume 56, Issue 1 , Page 190-193, January 1, 2025. The prevalence of transient ischemic attacks, ischemic stroke, and hemorrhagic stroke did not differ between patients with aPL-positive and aPL-negative MMA.CONCLUSIONS:The prevalence of aPL in patients with MMA is comparable to that in non-MMA controls.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombosis Hemorrhage Stroke 40

Stroke Journal

JANUARY 21, 2024

Stroke, Volume 55, Issue 2 , Page 269-277, February 1, 2024. Men exhibited more unstable plaques (P<0.001), characterized by increased plaque hemorrhage, larger lipid core, and inflammation (P<0.001), along with less favorable circulating profiles. years), the final study analyses included 317 men and 143 women (aged 71.0±9.0

Plaque 40

Plaque Circulation Atherosclerosis Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. of all strokes [1, 2]. These strokes primarily occur in the anterior spinal cord artery (ASA) and/or the posterior spinal cord artery (PCA) territory and can have widely variable clinical presentation.

Ischemia 40

Ischemia Myocardial Infarction Thrombosis Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP49-AWMP49, February 1, 2024. Introduction:COVID-19 infection has thus emerged to be a new risk factor for Cerebral Venous Thrombosis (CVT). CVT with COVID patients were more likely to develop deep vein thrombosis at one month (19.8% All-cause mortality was the primary outcome.

COVID-19 40

COVID-19 Outcomes Thrombosis Embolism 40